Aims To compare the incidence of gastrostomy complications with a primary gastrostomy versus gastrostomy with concurrent fundoplication and neurologically impaired versus neurologically normal children. Additionally two low profi le devices (LPD) one with balloon retention the other with silicone bolster retention were compared for their longevity. Methods Ninety eight patients (58 males, mean age 4.66 years) with 107 gastrostomies inserted between April 2004 and May 2008 were included in this retrospective, single institution audit. Follow up data was obtained up to June 2009, enabling a minimum follow up period of one year. The specifi c complications reviewed were tube related (malinsertion and malposition post LPD placement), site related (wound infection/breakdown confi rmed with swab, hypergranulation requiring treatment and skin excoriation requiring dressings). Logistic regression analysis was used with a statistical signifi cance defi ned as p value < 0.05. Results There were 63 primary gastrostomies and 44 with concurrent fundoplication, 71 children were neurologically impaired and 36 were neurologically normal. The mean follow up time was 35.6 ± 1.41 months. There were 4 malinsertions and 5 malpositions post low profi le device insertion with no association between primary gastrostomy and concurrent fundoplication or neurological status. While hypergranulation was a problem with 71-91% in all groups there was no statistical signifi cance between the groups. The odds of an infection with gastrostomy plus concurrent fundoplication are 2.38 times greater than for gastrostomy alone (95% CI, 1.02, 5.56; p = 0.02). The odds of excoriation are 2.50 times greater in patients receiving gastrostomy plus concurrent fundoplication than for gastrostomy alone (95% CI 1.09-5.71; p = 0.015). There was no statistical association with neurological impaired or neurological normal children. Low profi le device replacement rates were signifi cantly higher for those with balloon retention (1.77 per year) compared with silicone bolster retention (0.56 per year). Conclusion There is a higher incidence of site infection and skin excoriation for gastrostomy placement with concurrent fundoplication. There was no signifi cant difference between neurologically impaired compared with neurologically normal children. Low profi le balloon devices were changed three times more often than those with silicone bolster retention.
Defective bile acid transport and synthesis in a piglet model of short bowel syndrome associated-liver disease PM PEREIRA-FANTINI, 1 's Hospital, Parkville, 4 University of Melbourne SBS-ALD occurs in ∼65% of infants following small bowel resection (SBR) however the cause remains unknown. We have recently described a piglet model which mimics many of the features of SBS-ALD including hepatic fat droplet and bile acid accumulation. The aim of the current study was to characterise changes in enterohepatic bile acid synthesis and transport in our piglet model of SBS-ALD. Methods 4-week old piglets underwent a 75% small bowel resection (SBR) or sham operation and were studied at 0, 2, and 6 weeks postoperation. Stool and serum was taken weekly for LFTs and total bile acid determination (TBA). At sacrifi ce ileum and liver was removed for histological analysis, RT-PCR determination of target genes and bile acid tissue levels. Results In the liver there was no change in NTCP, BSEP, CYP7A1 or FXR mRNA. Signifi cant changes are tabled below. 
TBA
Ileum 21.7 ± 11.7 23.6 ± 9.8 26.5 ± 8.6 9.7 ± 2.0 15.7 ± 11.5 Liver 52.5 ± 7.5 36.3 ± 14.8 42.6 ± 5.4 10.3 ± 2.3 29.6 ± 2.2* Stool 39.9 ± 9.4 41.8 ± 6.1 71.4 ± 8.7* 53.3 ± 9.3 58.3 ± 5.9 Serum 3.9 ± 1.0 9.5 ± 0.7 8.8 ± 2.8 9.4 ± 2.8 18.6 ± 3.5* Ileum RT-PCR ASBT 12.0 ± 3.2 19.3 ± 4.5 53 ± 6*** 15.3 ± 2.8 31.5 ± 6.4 IL-BP 15.6 ± 4.5 36.0 ± 10.2 62.4 ± 8.4* 23.9 ± 5.1 37.5 ± 11.4 OSTA 15.0 ± 5.2 13.5 ± 5.2 18.7 ± 5.3 16.0 ± 4.5 3.8 ± 2.5* OSTB 22.8 ± 3.1 19.4 ± 2.2 21.5 ± 5.7 25.2 ± 4.5 14.9 ± 2.7 FXR 1.5 ± 0.3 1.5 ± 0.2 1.5 ± 0.4
Conclusion We have performed the fi rst concurrent study of intestine and liver using a model of SBS-associated liver disease. We have observed dysregulation of key molecules involved in bile acid synthesis and transport, including the nuclear receptor FXR.
BMI and gastroesophageal refl ux disease in children, is there an association?
Introduction Obesity is an epidemic in both adults and children with approximately 18% of Australian Children aged 2-18 yrs being overweight and a further 7% being obese. In adults, a positive association between weight and gastroesophageal refl ux has long been established however this association currently remains unclear in children. The aim of this study was to correlate Body Mass Index (BMI) with the occurrence of gastroesophageal refl ux (GOR) in children.
Methods A retrospective analysis of 24 h pH studies completed at the Women's & Children's Hospital between 2006 and 2010 was performed. Patient body weight and height were recorded and BMI was calculated.
Patients were divided into four BMI categories (underweight, normal weight, overweight and obese according to the WHO guidelines). GOR episodes and total acid exposure was recorded using a pH probe which remained in place for 24 h. Results 316 children (mean age 9.46 ± 4.5, 53% male) were included. When compared to normal weight children, overweight children had signifi cantly higher acid exposure and a greater frequency of acid refl ux (p = 0.004 and p < 0.001 respectively). Furthermore overweight children Introduction Mucositis is a serious disorder of the gastrointestinal tract that results from cancer chemotherapy. Previously, we have demonstrated that grape seed extract (GSE) partially reduced indicators of intestinal damage in a rat model of intestinal mucositis (Cheah et al. 2010) ; however, its impact on the effectiveness of chemotherapy against cancer cells is currently unknown. We investigated the combined effects of GSE and chemotherapy on colorectal cancer cells. Methods Caco-2 cells (5000 cells/well) were cultured in a 96-well tissue culture plates in DMEM media with 10% FCS for 48 hrs. Culture medium was replaced with serum free medium containing GSE (10, 25, 50, or 100 µg/mL) and 5-FU (5 Fluorouracil, 100 µM). The proliferative activity of cells was determined by MTT (3,4,5-Dimethylthiazol-2,5-diphenyltetrazolium bromide) assay at 24 and 48 hrs. Signifi cance was assumed at p < 0.05 using one-way ANOVA.
Results GSE treatments signifi cantly (p < 0.05) reduced the proliferative activity of Caco-2 cells compared to control value in a time-and dosedependent manner (IC 50 = 50.2 µg/mL, 24 hrs; IC 5 = 37.8 µg/mL, 48 hrs). At 24 hrs, 5-FU signifi cantly reduced cell viability to 86% (p < 0.05) of control value. The combination of 5-FU and GSE signifi cantly (p < 0.05), and dose-responsively, decreased the proliferative activity of Caco-2 cells (GSE 25 = 35%; GSE 50 = 67% and GSE 100 = 71%) compared to 5-FU control. At 48 hrs, 5-FU reduced Caco-2 cell viability to 71% (p < 0.05) of control value. 5-FU and GSE in combination signifi cantly (p < 0.05), and dose-responsively, decreased the proliferative activity (p < 0.05) of Caco-2 cells (GSE 25 = 23%; GSE 50 = 72%; GSE 100 = 73%) compared to 5-FU control. Conclusions We conclude that GSE not only reduced the proliferative activity of Caco-2 cells but also enhanced the capacity for 5-FU to reduce the proliferative activity of Caco-2 cells. Further studies are warranted to determine GSE effects on tumour growth in vivo. Our data provides the fi rst evidence of GSE enhancing the impact of chemotherapy on cancer cells. Dietary GSE could be a promising adjunctive approach to combat intestinal mucositis. Objectives Small bowel imaging is recommended in all children suspected or diagnosed to have Crohn's disease (CD) at diagnosis. Traditionally this was done by barium meal follow through. In recent years, experience has accumulated with the use of MRI to evaluate small bowel in CD. In this study, we aim to describe our experience with this modality of imaging. We attempted to correlate the Paediatric Crohn's Disease Activity Index (PCDAI) with the MRI features of small bowel children with Crohn's disease at diagnosis. Methods Princess Margaret Hospital is the only tertiary paediatric service in the state of Western Australia. Our centre has been using MRI imaging of small bowel in children with CD since 2004. Hospital records of all children with CD diagnosed since 2004 were reviewed for demographic details, PCDAI and MRI fi ndings. MR enterography is performed at 1.5 T fi eld strength with oral (Polyethylene glycol) and intravenous (Gadolinium) contrast and images were assessed by an experienced radiologist who was blinded to the PCDAI. Various MR imaging characteristics and overall MRI impression were reviewed for association with PCDAI using statistical software. Results A total of 57 children were diagnosed with Crohn's disease since 2004, of whom 43 had MRI evaluation of their small bowel, the majority with in 2 months of diagnosis. There were 25 males and 18 females. Median age at diagnosis was 12 years. The association between MRI diagnosis of small bowel involvement and PCDAI was statistically signifi cant (p value 0.01) Certain features of MRI were found to correlate strongly with PCDAI. Conclusion MR enterography correlates well with the disease activity of Paediatric Crohn's disease. It has the advantage over barium of having no radiation exposure. MRI should be considered as the choice of imaging in paediatric Crohn's disease, when available.
with positive serology, 3 had Marsh type 3 changes. Eight patients had mucosal abnormalities graded as Marsh type 1 and 2, 1 associated with positive serology and 7 associated with negative serology. The sensitivity and specifi city of serology as a marker of mucosal healing was 60% and 86% respectively. 78 (76%) questionnaires were completed, with 92% reporting good or excellent compliance with a GFD including 62% of those with abnormal biopsies.
Conclusions
The preliminary fi ndings of this audit suggest that serology may not be an optimum tool to detect mucosal healing in a child with CD on a GFD. Parent-reported dietary compliance determined by a validated questionnaire also did not correlate with mucosal fi ndings. Ongoing recruitment in this study is awaited to confi rm these fi ndings, and determine the ideal monitoring strategy for long-term follow-up of children with CD.
